High-level KDM1A expression in neuroblastomas is associated with an aggressive clinical course, and pharmacological inhibition of KDM1A significantly reduced growth of human neuroblastoma cell lines grown as xenografts in nude mice. This evidence concerns the gene KDM1A and neuroblastoma.